Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience
Titel:
Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs: the M. D. Anderson Cancer Center experience
Auteur:
Wheler, J.J. Tsimberidou, A.M. Hong, D.S. Naing, A. Falchook, G.S. Fu, S. Moulder, S. Stephen, B. Wen, S. Kurzrock, R.